Viemed Healthcare, Inc. provides technology-enabled, home-based healthcare solutions and chronic disease management in the United States. Company news centers on home medical equipment and post-acute healthcare services, including respiratory care, non-invasive ventilation, sleep and resupply offerings, oxygen therapy, chronic care, and women's health products and services delivered with clinical support in the home.
Recurring updates include quarterly and annual financial results, guidance, revenue mix, patient-start trends, capital expenditure expectations, share repurchase activity, investor presentations, and analyst coverage. Viemed's releases also discuss service-line diversification, medical equipment rental, sales and supply revenue, reimbursement and coverage documentation dynamics, and the contribution of its 2025 acquisition of Lehan's Medical Equipment.
Viemed Healthcare (VMD) announced a strategic investment of $2 million in ModoHealth, aimed at enhancing patient management and value-based care. The investment will fund the expansion of ModoHealth’s proprietary network, which integrates clinical tools, remote monitoring, and patient engagement. Viemed will receive an 18-month secured convertible promissory note and plans to leverage its expertise to improve outcomes for patients with respiratory issues like COPD and sleep apnea through ModoHealth's platform. This partnership reflects Viemed’s commitment to innovate in home healthcare delivery.
Viemed Healthcare, Inc. (NASDAQ:VMD) announced new syndicated credit facilities, featuring a senior secured revolving credit facility of up to $30 million and a delayed draw term loan of the same amount. The total borrowing capacity could reach $90 million due to an accordion feature. This move allows the company to enhance its financial flexibility and support future acquisitions, following the retirement of its previous credit facility. The company aims to use these proceeds primarily for refinancing existing debts, acquisitions, working capital, and capital expenditures.
Viemed Healthcare (NASDAQ:VMD) reported record net revenues of $35.8 million for Q3 2022, marking a 28% increase from Q3 2021. The company also achieved a sequential growth of 7% over the previous quarter. Ventilator patient count rose to 9,127, an 11% increase year-over-year. Adjusted EBITDA reached $7.0 million for Q3, totaling $20.7 million for the nine months ended September 30, 2022. Despite a decline in cash balance to $21.5 million from $28.4 million, the company anticipates Q4 revenues of $37.1 million to $38.1 million.
Viemed Healthcare, Inc. (NASDAQ:VMD) will host its Quarterly Conference Call on November 2, 2022 at 11:00 a.m. ET. Interested parties can join by calling 877-407-6176 (US) or 201-689-8451 (International).
Financial professionals are encouraged to pre-register by emailing investorinfo@viemed.com by 12:00 p.m. ET on November 1, 2022.
A live audio webcast will also be available, with replays accessible on Viemed's website following the call.
Viemed Healthcare, a provider of in-home medical equipment and post-acute respiratory care in the U.S., will present at Lake Street's 4th Annual Best Ideas Growth Conference on September 17, 2020. CEO Casey Hoyt and COO Todd Zehnder will engage with investors through one-on-one and group meetings. This invitation-only event features around 90 public growth companies and top institutional investors nationwide. For inquiries or to schedule meetings, contact Lake Street at conference@lakestreetcm.com.